Journal of Antimicrobial Chemotherapy (2000) 46, 639
© 2000 The British Society for Antimicrobial Chemotherapy
Correspondence |
Trends in antimicrobial prescribing
Department of Pharmacy, Withington Hospital, Nell Lane, West Didsbury, Manchester M20 2LR, UK
Sir,
The review by Gould & Jappy1 constitutes a useful survey of antimicrobial use over a decade, and on the face of
Notes
Reference
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Wootton, A. P. MacGowan, T. R. Walsh, and R. A. Howe A Multicenter Study Evaluating the Current Strategies for Isolating Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides J. Clin. Microbiol., February 1, 2007; 45(2): 329 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Skhirtladze, D. Hutschala, T. Fleck, F. Thalhammer, M. Ehrlich, T. Vukovich, M. Muller, and E. M. Tschernko Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac Surgery. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1372 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. J. Brown, D. I. Edwards, P. M. Hawkey, D. Morrison, G. L. Ridgway, K. J. Towner, M. W. D. Wren, and on behalf of the Joint Working Party of the Britis Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA) J. Antimicrob. Chemother., December 1, 2005; 56(6): 1000 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Snary, L. A. Kelly, H. C. Davison, C. J. Teale, and M. Wooldridge Antimicrobial resistance: a microbial risk assessment perspective J. Antimicrob. Chemother., June 1, 2004; 53(6): 906 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Kim, W. B. Park, K. D. Lee, Y. J. Choi, S. W. Park, M.-d. Oh, E.-C. Kim, and K. W. Choe Nationwide Surveillance for Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Korea J. Clin. Microbiol., June 1, 2003; 41(6): 2279 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-W. Decousser, P. Pina, F. Picot, C. Delalande, B. Pangon, P. Courvalin, P. Allouch, and the ColBVH study group Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey J. Antimicrob. Chemother., May 1, 2003; 51(5): 1213 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Manuel, A. Tuck, A. Lowes, and A. Pallett Detection of teicoplanin resistance in UK EMRSA-17 strains J. Antimicrob. Chemother., December 1, 2002; 50(6): 1089 - 1090. [Full Text] [PDF]
|
|
|
|
|
|
F. M. MacKenzie, P. Greig, D. Morrison, G. Edwards, and I. M. Gould Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland J. Antimicrob. Chemother., November 1, 2002; 50(5): 689 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Heym, M. Le Moal, L. Armand-Lefevre, and M.-H. Nicolas-Chanoine Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcusaureus has spread to France and acquired reduced susceptibility to teicoplanin J. Antimicrob. Chemother., September 1, 2002; 50(3): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Denis, C. Nonhoff, B. Byl, C. Knoop, S. Bobin-Dubreux, and M. J. Struelens Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features J. Antimicrob. Chemother., September 1, 2002; 50(3): 383 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Paton, T. Snell, F. X. S. Emmanuel, and R. S. Miles Glycopeptide resistance in an epidemic strain of methicillin-resistant Staphylococcus aureus J. Antimicrob. Chemother., December 1, 2001; 48(6): 941 - 942. [Full Text] [PDF]
|
|
|
|
|
|
M. H. Wilcox and W. Fawley Extremely low prevalence of UK Staphylococcus aureus isolates with reduced susceptibility to vancomycin J. Antimicrob. Chemother., July 1, 2001; 48(1): 144 - 145. [Full Text] [PDF]
|
|
|
|
|
|
T. R. Walsh, R. A. Howe, M. Wootton, P. M. Bennett, and A. P. MacGowan Detection of glycopeptide resistance in Staphylococcus aureus J. Antimicrob. Chemother., March 1, 2001; 47(3): 357 - 358. [Full Text] [PDF]
|
|